Bone Sarcomas clinical trials

Explore recruiting bone sarcomas clinical trials.

Recruiting bone sarcomas studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bone Sarcomas trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Metformin as maintenance therapy in bone sarcomas at high risk of relapse

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

REGOSTA – A multicentre exploratory phase II study describing the efficacy and safety of regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

REGOBONE_A Randomized Phase II, placebo-controlled, multicenter study evaluating efficacy and safety of regorafenib in patients with metastatic bone sarcomas

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase I-II trial of sunitinib and/or nivolumab plus chemotherapy in advanced soft tissue and bone sarcomas

Spain, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1b, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of Mipasetamab Uzoptirine (ADCT-601) Monotherapy and in Combination with Other Anti-Cancer Therapies in Patients with Selected Advanced Solid Tumors

France, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase IIa Clinical Trial: Feasibility Study on Non-Invasive Simultaneous Hyperpolarized [1-13C]Pyruvate Magnetic Resonance Spectroscopy and 18F-FDG PET (hyperPET) for Metabolic Imaging in Patients with Cancer

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Bone Sarcomas trials by city

Bone Sarcomas in Toronto Bone Sarcomas in Vancouver Bone Sarcomas in Montreal Bone Sarcomas in Calgary Bone Sarcomas in Edmonton Bone Sarcomas in Ottawa Bone Sarcomas in Winnipeg Bone Sarcomas in Quebec City Bone Sarcomas in Hamilton Bone Sarcomas in Kitchener Bone Sarcomas in London Bone Sarcomas in Halifax Bone Sarcomas in New York Bone Sarcomas in Los Angeles Bone Sarcomas in Chicago Bone Sarcomas in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease